Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on assets-65.3%+45.4pp-60.3%+26.6pp-97.1%-44.9pp-79.6%-31.9pp-110.7%-39.6pp
Liquidity
Current ratio14.3×-17.7×21.1×+15.3×+0.2×10.3×+3.8×32×+25.4×
Quick ratio14.3×-17.7×21.1×+15.3×+0.2×10.3×+3.8×32×+25.4×
Cash ratio2.5×-15.8×5.3×-0.4×2.2×-0.8×10.2×+8.4×18.3×+17.7×
Leverage
Debt-to-equity-681×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Interest coverage-13×+21.4×-14.6×+10.8×-19.5×-1.9×-25.5×-11.6×-34.4×-20.3×
Per Share
Book value per share$5.13+119%$10.60+171%$4.53+185%$7.09+2,363,000%-$26.46-909%
Valuation
Market capitalization$1.33B+318%$760.92M$281.57M$337.83M
Enterprise value$1.28B$673.33M$232.33M$117.7M
Price / book4.5×2.3×1.6×1.7×
Earnings yield-9.7%-16.7%-50.6%-39.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Jade Biosciences, Inc. Common Stock's ratios come from?
Every ratio is computed from Jade Biosciences, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.